Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1991 1
1996 2
1999 1
2000 5
2001 49
2002 58
2003 63
2004 81
2005 106
2006 85
2007 104
2008 104
2009 114
2010 131
2011 146
2012 191
2013 197
2014 216
2015 204
2016 234
2017 245
2018 241
2019 268
2020 268
2021 327
2022 373
2023 391
2024 148

Text availability

Article attribute

Article type

Publication date

Search Results

3,855 results

Results by year

Filters applied: . Clear all
Page 1
Mixed methods approach to examining the implementation experience of a phone-based survey for a SARS-CoV-2 test-negative case-control study in California.
Fukui N, Li SS, DeGuzman J, Myers JF, Openshaw J, Sharma A, Watt J, Lewnard JA, Jain S, Andrejko KL, Pry JM; California COVID-19 Case-Control Study Team. Fukui N, et al. PLoS One. 2024 May 21;19(5):e0301070. doi: 10.1371/journal.pone.0301070. eCollection 2024. PLoS One. 2024. PMID: 38771784 Free article.
Differential Burden of HIV Among Adolescent Girls and Young Women by Places Associated With Sex Work: An Observational Study in Mombasa, Kenya.
Becker M, Mishra S, Bhattacharjee P, Musyoki H, Tennakoon A, Leung S, Cheuk E, Lorway R, Isac S, Ma H, Cholette F, Sandstrom P, Gichangi P, Mwatelah R, Mckinnon L, Blanchard J, Pickles M; Transitions Study Team. Becker M, et al. J Acquir Immune Defic Syndr. 2024 Jun 1;96(2):121-129. doi: 10.1097/QAI.0000000000003412. J Acquir Immune Defic Syndr. 2024. PMID: 38771751
Comparing patterns of recent and remote Mycobacterium tuberculosis infection determined using the QuantiFERON-TB Gold Plus assay in a high TB burden setting.
Amofa-Sekyi M, Schaap A, Mureithi L, Kosloff B, Cheeba M, Kangololo B, Vermaak R, Paulsen R, Ruperez M, Floyd S, de Haas P, Fidler S, Hayes R, Ayles H, Shanaube K; TREATS study team. Amofa-Sekyi M, et al. PLOS Glob Public Health. 2024 May 20;4(5):e0003182. doi: 10.1371/journal.pgph.0003182. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 38768253 Free PMC article.
Pharmacokinetics of Generic Pediatric Dolutegravir Dispersible Tablet in Thai Young Children Living With HIV Weighing Below Twenty Kilograms.
Rungsapphaiboon A, Wacharachaisurapol N, Anugulruengkitt S, Sirikutt P, Phasomsap C, Tawan M, Saisaengjan C, Na Nakorn Y, Paiboon N, Songtaweesin WN, Tawon Y, Cressey TR, Puthanakit T; DTGkids Study Team. Rungsapphaiboon A, et al. Pediatr Infect Dis J. 2024 May 20. doi: 10.1097/INF.0000000000004366. Online ahead of print. Pediatr Infect Dis J. 2024. PMID: 38768047
Population pharmacokinetics of ravidasvir in adults with chronic hepatitis C virus infection and impact of antiretroviral treatment.
Panjasawatwong N, Avihingsanon A, Menétrey C, Ribeiro I, Salvadori N, Swanson A, Gillon J-Y, Tan S-S, Thanprasertsuk S, Thongsawat S, Cressey TR; STORM-C-1 study team. Panjasawatwong N, et al. Antimicrob Agents Chemother. 2024 May 20:e0000824. doi: 10.1128/aac.00008-24. Online ahead of print. Antimicrob Agents Chemother. 2024. PMID: 38767383
Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial.
Corado KC, Chew KW, Giganti MJ, Mu Y, Fletcher CV, Currier JS, Daar ES, Wohl DA, Li JZ, Moser CB, Ritz J, Javan AC, Neytman G, Caskey M, Hughes MD, Smith DM, Eron JJ; ACTIV-2/A5401 Study Team. Corado KC, et al. Pathog Immun. 2024 May 6;9(1):138-155. doi: 10.20411/pai.v9i1.660. eCollection 2024. Pathog Immun. 2024. PMID: 38746756 Free PMC article.
Effectiveness of double-dose dolutegravir in people receiving rifampin-based tuberculosis treatment: an observational, cohort study of people with HIV from six countries.
Shah NS, Kityo C, Hughes MD, McCarthy C, Wallis C, Hosseinipour M, Langat D, Nyirenda M, Rassool M, Dawson R, Joseph Y, Some F, Mngqbisa R, Mukwekwerere PG, Woolley E, Godfrey C, Manabe YC, Mellors JW, Flexner C, Maartens G; ACTG A5381/Hakim Study Team. Shah NS, et al. Clin Infect Dis. 2024 May 13:ciae269. doi: 10.1093/cid/ciae269. Online ahead of print. Clin Infect Dis. 2024. PMID: 38739755
3,855 results